Extensive cortical spongiform changes with cerebellar small amyloid plaques: The clinicopathological case of MV2K+C subtype in Creutzfeldt‐Jakob disease

We report a clinical case report of the MV2K+C subtype of sporadic Creutzfeldt‐Jakob disease (sCJD). The patient was a 72‐year‐old woman who exhibited progressive dementia over the course of 22 months. Diffusion‐weighted MRI during this period showed abnormal hyperintensity in the cerebral cortex in the early stage. The clinical course was similar to that of previously reported patients with the MV2K or MV2K+C subtype of sCJD. However, histopathological examination revealed unique features: severe extensive spongiform changes with perivacuolar deposits in the cerebrum and basal ganglia, plaque‐like PrP deposits in the cerebrum, and only mild changes in the cerebellum with small amyloid plaques (∼20 μm in diameter), smaller than those in the MV2K subtype or variant CJD (40–50 μm in diameter). Molecular analysis showed a methionine/valine heterozygosity at codon 129 and no pathogenic mutation in the PrP gene (PRNP). Western blot analysis of the protease‐resistant PrP (PrPSc) in the right temporal pole revealed the type 2 pattern, which is characterized by a single unglycosylated band, in contrast to the doublet described for the typical MV2 subtype of sCJD. The other intermediate band might exist in the cerebellum with kuru plaques. Therefore, small amyloid plaques in the cerebellum can be crucial for MV2K+C subtype.

[1]  Y. Matsuura,et al.  Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein , 2013, Acta neuropathologica communications.

[2]  I. Ferrer,et al.  Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA , 2012, Acta Neuropathologica.

[3]  A. Giese,et al.  Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future , 2010, Acta Neuropathologica.

[4]  A. Aguzzi,et al.  Experimental Verification of a Traceback Phenomenon in Prion Infection , 2010, Journal of Virology.

[5]  B. Ghetti,et al.  Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification , 2009, Acta Neuropathologica.

[6]  D. Galanaud,et al.  MRI lesion profiles in sporadic Creutzfeldt–Jakob disease , 2009, Neurology.

[7]  S. Mohri,et al.  Human Prion Protein (PrP) 219K Is Converted to PrPSc but Shows Heterozygous Inhibition in Variant Creutzfeldt-Jakob Disease Infection* , 2009, Journal of Biological Chemistry.

[8]  I. Ferrer,et al.  A patient with MV2 subtype of sporadic Creutzfeldt-Jakob disease and atypical clinical presentation. , 2008, Clinical neuropathology.

[9]  J. Shiota,et al.  Severe cortical involvement in MV2 Creutzfeldt–Jakob disease: An autopsy case report , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[10]  K. Kallenberg,et al.  Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. , 2006, Brain : a journal of neurology.

[11]  B. Ghetti,et al.  Genetic influence on the structural variations of the abnormal prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[13]  M. Zeidler,et al.  WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease , 1998 .